Category Archives: Cancer Therapy

Cancer Treatment Centers of America: Healing with a Personal Touch

The fight against cancer is not in any way easy. The lack of high quality and timely treatment is one of the biggest challenges facing many cancer patients, leaving devastating effects on them. Luckily the entrance of Cancer Treatment Centers of America (CTCA) changed everything in the way patients receive treatment and care.

In the Hands of Only the Best

There are five hospitals operating under CTCA, whose headquarters are located in Boca Raton, Florida. They are based in Phoenix, Atlanta, Philadelphia, Tulsa and Chicago and serve not only the area residents but also patients from all over the world. All the CTCA hospitals are staffed by some of the most experienced cancer treatment experts who have at their disposal the most advanced technologies.

Every hospital takes a conventional approach for treatment of cancer including chemotherapy, immunotherapy, and surgery. However, the experts go a step further to deliver supportive therapies in a successful effort to help patients deal with the side-effects related to cancer and its treatment. Above all, every treatment is personalized.

Strong Partnerships

In a bid to provide even better treatment and care to its patients, CTCA struck a partnership with Allscripts and NantHealth. Together, the three entities have succeeded in providing more options for treatment as well as greatly improving efficiency and safety. The partnership involves the use of eviti, a clinical decision support solution by NantHealth, and NantHealth’s Clinical Pathways, a program aimed at reduction of variability and enabling better transparency in selection of therapeutic treatment and care for patients by providing evolving data for cancer care. All the way, the CTCA care standards are adhered to.


The Cancer Treatment Centers of America hospitals are recognized as some of the top-most performers in the fight against cancer. They have received five-star ratings on quality from the United States’ Centers for Medicare and Medicaid Services. In addition, many other healthcare organizations have applauded CTCA for its efforts. They include the National Accreditation Program for Breast Centers (NABPC), American College of Radiology, and Association of Community Cancer Centers. The partnership with Allscripts and NantHealth is sure to greatly improve delivery of treatment and care to CTCA patients as well as move the already high ratings higher.

Clay Siegall: How Seattle Genetics’ CEO Is Revolutionizing Cancer Therapy

Clay Siegall has cemented his status as one of the leading scientists in cancer therapy in the U.S. His immense experience and vast knowledge have earned him admiration and respect from his peers and colleagues from various walks of life.

Clay Siegall’s Role at Seattle Genetics

For over a decade, cancer has been a nagging disorder to most patients. Not only are they robbed off good health but they also have to settle huge medical bills accrued in various medical centers. Mr. Siegall deemed it necessary to develop Seattle Genetics in 1998, with the sole purpose of spearheading research on cancer therapies. By serving as the company’s CEO and Chairman of the Board, he has remarkably invigorated research training & techniques and expedited the development of drug practices. While at the helm, he is credited with pioneering the development of ADCs such as ADCETRIS, which is now a global brand across 60 countries worldwide.

By yielding positive results, ADCETRIS has instigated the development of other cancer remedies which are currently in the company’s pipeline. Additionally, Siegall has also played a valuable role in the generation of $ 325 million courtesy of lucrative contracts with leading clinical firms across the medical realm. Companies such as GlaxoSmithKline and Pfizer and Genentech have lauded the positive impacts made by the formidable partnership. An additional $1.2 billion has also been raised courtesy of private and public rounds of financing.

Clay Siegall’s Role in the Cancer Research Community

Having developed ADCETRIS, Siegall has embarked on a groundbreaking mission to broaden the drug’s application across numerous patients. The highly publicized campaign aims at establishing Seattle Genetics as the core cancer therapy institution in the U.S. According to Siegall, the clinical drug is currently under experiment in over 70 lymphoma patients with the anticipation of positive results. Based on recent findings, the clinical trial has yielded positive results in the diagnosis of Hodgkin lymphoma. With such results, ADCETRIS has eclipsed any achievement made in the year.

Apart from the research exploits, Siegall has also launched an ambitious plan to hire an additional 100 employees to supplement the development of 12 more clinical cancer therapies.